| 2025 | 2024 | 2022 | 2021 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -33,7 k € | -4.0% | -32,4 k € | +0.6% | -32,6 k € | -176.4% | -11,8 k € | +79.7% | -58,0 k € | +57.8% | -137,4 k € | -2.0% | -134,8 k € | -23.9% | -108,8 k € | +21.3% | -138,2 k € | +49.2% | -271,9 k € | +28.8% | -382,0 k € | -1.0% | -378,3 k € | |
| EBITDA | -33,7 k € | -4.0% | -32,4 k € | +0.6% | -32,6 k € | -176.4% | -11,8 k € | +79.7% | -58,0 k € | +57.8% | -137,4 k € | -2.0% | -134,8 k € | +89.7% | -1,3 M € | -847.8% | -138,2 k € | +49.2% | -271,9 k € | +28.8% | -382,1 k € | -1.0% | -378,3 k € | |
| Operating profit | -33,7 k € | -4.0% | -32,4 k € | +0.6% | -32,6 k € | -176.4% | -11,8 k € | +79.7% | -58,0 k € | +57.8% | -137,4 k € | -2.0% | -134,8 k € | +89.7% | -1,3 M € | -847.8% | -138,2 k € | +49.2% | -271,9 k € | +28.8% | -382,1 k € | -1.0% | -378,3 k € | |
| Profit/loss | -16,1 k € | +50.8% | -32,8 k € | +1.0% | -33,1 k € | -178.6% | -11,9 k € | +99.2% | -1,4 M € | -320.7% | 651,3 k € | +126.3% | -2,5 M € | -91.4% | -1,3 M € | -158.4% | -500,9 k € | +54.0% | -1,1 M € | +63.8% | -3,0 M € | -700.9% | -376,2 k € | |
| Equity | 1,6 M € | -1.0% | 1,6 M € | -33.8% | 2,5 M € | -1.3% | 2,5 M € | -0.5% | 2,5 M € | -36.2% | 4,0 M € | +19.6% | 3,3 M € | -34.2% | 5,0 M € | -20.4% | 6,3 M € | +38.1% | 4,6 M € | +33.8% | 3,4 M € | -32.6% | 5,1 M € | |
| Total assets | 1,6 M € | -3.6% | 1,7 M € | -31.8% | 2,5 M € | -1.6% | 2,5 M € | -0.1% | 2,5 M € | -36.3% | 4,0 M € | +18.5% | 3,4 M € | -33.9% | 5,1 M € | -20.0% | 6,3 M € | +37.9% | 4,6 M € | +33.9% | 3,4 M € | -32.5% | 5,1 M € | |
| Cash | 78,4 k € | -43.6% | 139,0 k € | -8.0% | 151,0 k € | -21.4% | 192,1 k € | -1.8% | 195,6 k € | +109.5% | 93,3 k € | -64.3% | 261,3 k € | -51.9% | 543,5 k € | -72.5% | 2,0 M € | +603.0% | 281,0 k € | -50.9% | 571,8 k € | +21519.1% | 2,6 k € | |
| Debts | 6,3 k € | -87.7% | 50,8 k € | +11234.6% | 448,0 € | -94.7% | 8,4 k € | +70300.0% | 12,0 € | -99.8% | 7,0 k € | -81.2% | 37,1 k € | +28.6% | 28,9 k € | +411.9% | 5,6 k € | -44.0% | 10,1 k € | +90.6% | 5,3 k € | +2359.1% | 215,1 € | |
Public limited company · Zaventem · incorporated on 05/08/2011
Company — Dissolution volontaire – liquidation.
Public limited company loss-making in the latest fiscal year. Cash position declining (-43.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
| Unit no. | Name | Location |
|---|---|---|
| 2201907324 | Vesalius Biocapital II ARKIV | Rue Ducale 67 box 6, 1000 Bruxelles |
Vesalius Biocapital II ARKIV is a Public limited company incorporated in 2011. Its registered office is in Zaventem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette